ジェネリック医薬品市場は2023年から2028年に2,125億8,000万米ドル、予測期間中のCAGRは7.86%で成長すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場を牽引しているのは、ブランド医薬品に代わる低コストの医薬品、創薬や市場開拓のアウトソーシングの増加、ブランド医薬品の特許切れの増加などです。
本調査では、RPA（ロボティック・プロセス・オートメーション）の登場が今後数年間のジェネリック医薬品市場成長を牽引する主要因の1つであると分析しています。また、市場ベンダー間のM＆Aの上昇や病院が所有するジェネリック医薬品の出現は、市場の大規模な需要につながります。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
4.1 Global generic drugs market 2018 - 2022
4.2 Route of administration Segment Analysis 2018 - 2022
4.3 Type Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by Route of Administration
6.1 Market segments
6.2 Comparison by Route of Administration
6.3 Oral - Market size and forecast 2023-2028
6.4 Injectables - Market size and forecast 2023-2028
6.5 Topical - Market size and forecast 2023-2028
6.6 Inhalers - Market size and forecast 2023-2028
6.7 Market opportunity by Route of Administration
7 Market Segmentation by Type
7.1 Market segments
7.2 Comparison by Type
7.3 Small-molecule generics - Market size and forecast 2023-2028
7.4 Biosimilars - Market size and forecast 2023-2028
7.5 Market opportunity by Type
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 Germany - Market size and forecast 2023-2028
9.9 China - Market size and forecast 2023-2028
9.10 UK - Market size and forecast 2023-2028
9.11 India - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Amgen Inc.
12.4 Aurobindo Pharma Ltd.
12.5 Baxter International Inc.
12.6 Biocon Ltd.
12.7 Cadila Pharmaceuticals Ltd.
12.8 Cipla Ltd.
12.9 Dr Reddys Laboratories Ltd.
12.10 Fresenius SE and Co. KGaA
12.11 Merck and Co. Inc.
12.12 Novartis AG
12.13 Pfizer Inc.
12.14 Sanofi SA
12.15 Sun Pharmaceutical Industries Ltd.
12.16 Teva Pharmaceutical Industries Ltd.
12.17 Viatris Inc.
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global generic drugs market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Route of administration Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits31: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Injectables - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Injectables - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Injectables - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Topical - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Topical - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Topical - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Topical - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Inhalers - Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on Inhalers - Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on Inhalers - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Inhalers - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Route of Administration ($ billion)
Exhibits51: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits52: Chart on Type - Market share 2023-2028 (%)
Exhibits53: Data Table on Type - Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by Type
Exhibits55: Data Table on Comparison by Type
Exhibits56: Chart on Small-molecule generics - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Small-molecule generics - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Small-molecule generics - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Small-molecule generics - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Biosimilars - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Biosimilars - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Biosimilars - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Biosimilars - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Type ($ billion)
Exhibits65: Data Table on Market opportunity by Type ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Amgen Inc. - Overview
Exhibits116: Amgen Inc. - Product / Service
Exhibits117: Amgen Inc. - Key offerings
Exhibits118: Aurobindo Pharma Ltd. - Overview
Exhibits119: Aurobindo Pharma Ltd. - Product / Service
Exhibits120: Aurobindo Pharma Ltd. - Key offerings
Exhibits121: Baxter International Inc. - Overview
Exhibits122: Baxter International Inc. - Business segments
Exhibits123: Baxter International Inc. - Key news
Exhibits124: Baxter International Inc. - Key offerings
Exhibits125: Baxter International Inc. - Segment focus
Exhibits126: Biocon Ltd. - Overview
Exhibits127: Biocon Ltd. - Business segments
Exhibits128: Biocon Ltd. - Key news
Exhibits129: Biocon Ltd. - Key offerings
Exhibits130: Biocon Ltd. - Segment focus
Exhibits131: Cadila Pharmaceuticals Ltd. - Overview
Exhibits132: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits133: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits134: Cipla Ltd. - Overview
Exhibits135: Cipla Ltd. - Business segments
Exhibits136: Cipla Ltd. - Key news
Exhibits137: Cipla Ltd. - Key offerings
Exhibits138: Cipla Ltd. - Segment focus
Exhibits139: Dr Reddys Laboratories Ltd. - Overview
Exhibits140: Dr Reddys Laboratories Ltd. - Business segments
Exhibits141: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits142: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits143: Fresenius SE and Co. KGaA - Overview
Exhibits144: Fresenius SE and Co. KGaA - Business segments
Exhibits145: Fresenius SE and Co. KGaA - Key news
Exhibits146: Fresenius SE and Co. KGaA - Key offerings
Exhibits147: Fresenius SE and Co. KGaA - Segment focus
Exhibits148: Merck and Co. Inc. - Overview
Exhibits149: Merck and Co. Inc. - Business segments
Exhibits150: Merck and Co. Inc. - Key news
Exhibits151: Merck and Co. Inc. - Key offerings
Exhibits152: Merck and Co. Inc. - Segment focus
Exhibits153: Novartis AG - Overview
Exhibits154: Novartis AG - Business segments
Exhibits155: Novartis AG - Key news
Exhibits156: Novartis AG - Key offerings
Exhibits157: Novartis AG - Segment focus
Exhibits158: Pfizer Inc. - Overview
Exhibits159: Pfizer Inc. - Product / Service
Exhibits160: Pfizer Inc. - Key news
Exhibits161: Pfizer Inc. - Key offerings
Exhibits162: Sanofi SA - Overview
Exhibits163: Sanofi SA - Business segments
Exhibits164: Sanofi SA - Key news
Exhibits165: Sanofi SA - Key offerings
Exhibits166: Sanofi SA - Segment focus
Exhibits167: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits168: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits169: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits170: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits171: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits172: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits173: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits174: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits175: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits176: Viatris Inc. - Overview
Exhibits177: Viatris Inc. - Business segments
Exhibits178: Viatris Inc. - Key news
Exhibits179: Viatris Inc. - Key offerings
Exhibits180: Viatris Inc. - Segment focus
Exhibits181: Inclusions checklist
Exhibits182: Exclusions checklist
Exhibits183: Currency conversion rates for US$
Exhibits184: Research methodology
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Information sources
Exhibits187: List of abbreviations
